Clinical Trials Arena January 23, 2024
Joshua Silverwood

The study was designed to assess the equivalence of visual acuity measurements between Tilak Healthcare’s OdySight app, and traditional eyesight checks.

French digital health firm, Tilak Healthcare, has announced positive results from a clinical trial of a mobile app aimed at allowing patients with chronic macular degeneration to monitor their eyesight.

TIL002, a multicentre trial taking place across three French hospitals, demonstrated that theCE-marked OdySight app showed a high level of concordance between itself and traditional methods of testing for eyesight decline.

The app allows patients to carry out regular monitoring of their visual acuity through eye tests that they perform themselves, with the results forwarded to the patient’s clinicians.

...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Apps, Biotechnology, Clinical Trials, Digital Health, Pharma, Pharma / Biotech, Technology, Trends
Medicare insurers ranked by mobile app quality
How an App Store Approach Fuels Innovation and Efficiency in Healthcare
'The generation that created the internet is now our audience': SCAN Group prepares to launch first mobile app
Apple’s Vision Pro has a problem a year into its existence: Not enough apps
Research reveals concerning links between fitness apps and disordered eating

Share This Article